CANY
RARX

Caxton Associates (New York)’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Caxton Associates (New York)’s Portfolio RARX Stock Details RARX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,049
Closed -$434K – 677
2020
Q1 		$434K Buy
+9,049
New +$434K 0.08% 180